Volume 52, Issue 33 pp. 8620-8624
Communication

Lysine-Specific Demethylase 1-Selective Inactivators: Protein-Targeted Drug Delivery Mechanism

Daisuke Ogasawara

Daisuke Ogasawara

Graduate School of Medical Science, Kyoto Prefectural University of Medicine, 13 Nishitakatsukasa-cho, Taishogun Kita-ku, Kyoto 603-8334 (Japan)

Graduate School of Pharmaceutical Sciences, Nagoya City University, 3-1 Tanabe-dori, Mizuho-ku, Nagoya, Aichi 467-8603 (Japan)

Search for more papers by this author
Dr. Yukihiro Itoh

Dr. Yukihiro Itoh

Graduate School of Medical Science, Kyoto Prefectural University of Medicine, 13 Nishitakatsukasa-cho, Taishogun Kita-ku, Kyoto 603-8334 (Japan)

Search for more papers by this author
Dr. Hiroki Tsumoto

Dr. Hiroki Tsumoto

World-Leading Drug Discovery Research Center, Kyoto University, Kyoto 606-8501 (Japan)

Search for more papers by this author
Dr. Taeko Kakizawa

Dr. Taeko Kakizawa

Organic Chemistry National Institute of Health Sciences, Tokyo 158-8501 (Japan)

Search for more papers by this author
Dr. Koshiki Mino

Dr. Koshiki Mino

Graduate School of Bio-Science, Nagahama Institute of Bio-Science Technology, 1226 Tamura-cho, Nagahama, Shiga 526-0829 (Japan)

Search for more papers by this author
Dr. Kiyoshi Fukuhara

Dr. Kiyoshi Fukuhara

Organic Chemistry National Institute of Health Sciences, Tokyo 158-8501 (Japan)

Search for more papers by this author
Prof. Hidehiko Nakagawa

Prof. Hidehiko Nakagawa

Graduate School of Pharmaceutical Sciences, Nagoya City University, 3-1 Tanabe-dori, Mizuho-ku, Nagoya, Aichi 467-8603 (Japan)

Search for more papers by this author
Dr. Makoto Hasegawa

Dr. Makoto Hasegawa

Graduate School of Bio-Science, Nagahama Institute of Bio-Science Technology, 1226 Tamura-cho, Nagahama, Shiga 526-0829 (Japan)

Search for more papers by this author
Dr. Ryuzo Sasaki

Dr. Ryuzo Sasaki

Frontier Pharma Inc., Shiga 526-0829 (Japan)

Search for more papers by this author
Prof. Tamio Mizukami

Corresponding Author

Prof. Tamio Mizukami

Graduate School of Bio-Science, Nagahama Institute of Bio-Science Technology, 1226 Tamura-cho, Nagahama, Shiga 526-0829 (Japan)

Tamio Mizukami, Graduate School of Bio-Science, Nagahama Institute of Bio-Science Technology, 1226 Tamura-cho, Nagahama, Shiga 526-0829 (Japan)

Naoki Miyata, Graduate School of Pharmaceutical Sciences, Nagoya City University, 3-1 Tanabe-dori, Mizuho-ku, Nagoya, Aichi 467-8603 (Japan)

Takayoshi Suzuki, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, 13 Nishitakatsukasa-cho, Taishogun Kita-ku, Kyoto 603-8334 (Japan)

Search for more papers by this author
Prof. Naoki Miyata

Corresponding Author

Prof. Naoki Miyata

Graduate School of Pharmaceutical Sciences, Nagoya City University, 3-1 Tanabe-dori, Mizuho-ku, Nagoya, Aichi 467-8603 (Japan)

Tamio Mizukami, Graduate School of Bio-Science, Nagahama Institute of Bio-Science Technology, 1226 Tamura-cho, Nagahama, Shiga 526-0829 (Japan)

Naoki Miyata, Graduate School of Pharmaceutical Sciences, Nagoya City University, 3-1 Tanabe-dori, Mizuho-ku, Nagoya, Aichi 467-8603 (Japan)

Takayoshi Suzuki, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, 13 Nishitakatsukasa-cho, Taishogun Kita-ku, Kyoto 603-8334 (Japan)

Search for more papers by this author
Prof. Takayoshi Suzuki

Corresponding Author

Prof. Takayoshi Suzuki

Graduate School of Medical Science, Kyoto Prefectural University of Medicine, 13 Nishitakatsukasa-cho, Taishogun Kita-ku, Kyoto 603-8334 (Japan)

PRESTO (Japan) Science and Technology Agency (JST), Saitama 332-0012 (Japan)

Tamio Mizukami, Graduate School of Bio-Science, Nagahama Institute of Bio-Science Technology, 1226 Tamura-cho, Nagahama, Shiga 526-0829 (Japan)

Naoki Miyata, Graduate School of Pharmaceutical Sciences, Nagoya City University, 3-1 Tanabe-dori, Mizuho-ku, Nagoya, Aichi 467-8603 (Japan)

Takayoshi Suzuki, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, 13 Nishitakatsukasa-cho, Taishogun Kita-ku, Kyoto 603-8334 (Japan)

Search for more papers by this author
First published: 03 July 2013
Citations: 73

We thank Mie Tsuchida, Dr. Yasunao Hattori, and Prof. Kenichi Akaji for their technical support. This work was supported in part by JST PRESTO program (T.S.), a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (T.S. and Y.I.), Ho-ansha Foundation (T.S), Takeda Science Foundation (T.S.), Naito Foundation (T.S.), and NOVARTIS Foundation (Japan) for the promotion of science (T.S.).

Graphical Abstract

Drug drop off: Given that lysine-specific demethylase 1 (LSD1) could be potently and selectively inactivated by delivering phenylcyclopropylamine (PCPA), a weak and nonselective LSD1 inhibitor, directly to the enzyme's active site, a novel series of LSD1 inactivators (1) were designed. Biological and mechanistic studies indicate that 1 inhibits LSD1 potently and selectively.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.